MicroRNA-34a regulates brain-derived neurotrophic factor in an intracerebral hemorrhage model

MicroRNA-34a regulates brain-derived neurotrophic factor in an intracerebral hemorrhage model

: Intracerebral hemorrhages (ICHs) are devastating neurological events frequently resulting in a serious negative prognosis. The exact physiological and disease processes involved in ICHs are complex, but are thought to involve microRNAs (miRNAs), 22 nucleotide small noncoding RNAs that control a variety of normal physiological and disease processes. In this study, we show that a miRNA, miR-34a, regulates BDNF in a model of ICH injury. In particular, we assessed the impact of AM34a, an inhibitor of miR-34a, on the toxicity of thrombin-induced apoptosis and on BDNF-mediated signaling. We investigated the increased expression of miR-34a after an ICH-induced thrombin toxicity injury using a real-time polymerase chain reaction (RT-PCR) and evaluated miR-34a as a therapeutic target. Apoptosis was confirmed by 4 ,6-diamidino-2-phenylindole using terminal deoxynucleotidyl transferase-mediated digoxigenindUTP-biotin nick-end labeling (TUNEL). The number of apoptotic cells detected by TUNEL after ICH injury was decreased by AM34a. Additionally, the ICH injury model treated with AM34a had a significantly lower caspase-3 level. We performed western blot analyses for BDNF, phosphorylated Akt, and phosphorylated ERK. The levels of BDNF were significantly higher in samples treated with AM34a. Furthermore, the level of phosphorylated Akt and phosphorylated ERK were significantly higher under AM34a. In conclusion, we demonstrated a distinct miRNA expression pattern after an in vitro ICH injury model, and modulation of this pattern can have therapeutic potential. miR-34a antagomir reduced cell death and enhanced neurological recovery by activating the BDNF pro-survival pathway. This suggests that inhibiting miR-34a might be a potential therapeutic target in ICH.

___

  • Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti di Val Cervo P, Nicotera P, McKeon F, Knight RA, Mak TW et al (2011). Neuronal differentiation by TAp73 is mediated by microRNA- 34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A 27: 21093-21108.
  • Baek SS, Jun TW, Kim KJ, Shin MS, Kang SY, Kim CJ (2012). Effects of postnatal treadmill exercise on apoptotic neuronal cell death and cell proliferation of maternal-separated rat pups. Brain Dev 34: 45-56.
  • Beaudoin GM 3rd, Lee SH, Singh D, Yuan Y, Ng YG, Reichardt LF, Arikkath J (2012). Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat Protoc 7: 1741- 1754.
  • Benchoua A, Braudeau J, Reis A, Couriaud C, Onténiente B (2004). Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J Cereb Blood Flow Metab 24: 12721279.
  • Donnan GA, Fisher M, Macleod M, Davis SM (2008). Stroke. Lancet 371: 1612-1623.
  • Gomez-Pinilla F, Vaynman S (2005). A ‘deficient environment’ in prenatal life may compromise systems important for cognitive function by affecting BDNF in the hippocampus. Exp Neurol 192: 235243.
  • Hu S, Wang H, Chen K, Cheng P, Gao S, Liu J, Li X, Sun X (2015). MicroRNA-34c downregulation ameliorates amyloid-β- induced synaptic failure and memory deficits by targeting VAMP2. J Alzheimers Dis 48: 673-686.
  • Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G,Sano T, O’Tuathaigh C, Waddington JL, Prenter S et al (2012). Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressing effects. Nat Med 18: 1087-1094.
  • Kim VN, Han J, Siomi MC (2009). Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
  • Kloosterman WP, Plasterk RH (2006). The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
  • Koide H, Asai T, Furuya K, Tsuzuku T, Kato H, Dewa T, Nango M, Maeda N, Oku N (2011). Inhibition of Akt (ser473) phosphorylation and rapamycinresistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor1targeting vector. Biol Pharm Bull 34: 602608.
  • Lau NC, Lim LP, Weinstein EG, Bartel DP (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
  • Lee ST, Chu K, Jung KH, Yoon HJ, Jeon D, Kang KM, Park KH, Bae EK, Kim M, Lee SK et al. (2010). MicroRNAs induced during ischemic preconditioning. Stroke 41: 1646-1651.
  • Levi M, Levi JH, Andersen HF, Truloff D (2010) .Safety of recombinant activated factor VII in randomized clinical trial. N Engl J Med 363: 1791-1800.
  • Li Y, Jiang Y, Wan Y, Zhang L, Tang W, Ma J, Wu S, Cheng W (2013). Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway. Biomed Res 27: 43-50.
  • Liu N, Landreh M, Cao K, Abe M, Hendriks GJ, Kennerdell JR, Zhu Y, Wang LS, Bonini NM (2012). The microRNA miR- 34 modulates ageing and neurodegeneration in Drosophila. Nature 15: 519-523.
  • Lubinus M, Meier KE, Smith EA, Gause KC, LeRoy EC, Trojanowska M (1994). Independent effects of platelet derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J Biol Chem 269: 9822-9825.
  • Matsushita K, Meng W, Wang X, Asahi M, Asahi K, Moskowitz MA, Lo EH (2000). Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab 20: 396404.
  • Minichiello L (2009). TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10: 850-860.
  • Plesnila N, Zinkel S, Amin-Hanjani S, Qiu J, Korsmeyer SJ, Moskowitz MA (2002). Function of BID - a molecule of the bcl-2 family - in ischemic cell death in the brain. Eur Surg Res 34: 3741.
  • Qureshi AI (2003). Nonsteroidal anti-inflammatory drugs and the risk of intracerebral hemorrhage. Stroke 34: 379-386.
  • Qureshi AI, Mendelow AD, Hanley DF (2009). Intracerebral hemorrhage. Lancet 373: 1632-1644.
  • Shin DY, Kim GY, Lee JH, Choi BT, Yoo YH, Choi YH (2012). Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways. Int J Mol Sci 13: 14158-14171.
  • Stefani G, Slack FJ (2008). Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
  • Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer’s disease, inhibits bcl2 translation. Brain Res Bull 28: 268-273.
  • Zimmerberg B, Foote HE, Van Kempen TA (2009). Olfactory association learning and brain-derived neurotrophic factor in an animal model of early deprivation. Dev Psychobiol 51: 333344.
  • Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, Farinelli L, Delalle I, Schmitt A, Falkai P et al (2011). microRNA-34c is a novel target to treat dementias. EMBO J 23: 4299-4308.